Related Blog Posts
Activation of immune cells in the central nervous system leads to the release of proinflammatory factors
8 hours ago ago from ETS Surgery
There is also growing evidence that inflammation in the brain (neuroinflammation) might play the primary role in the pathogenesis of a number of neurodegenerative diseases like Alzheimer's disease (AD) and Parkisons disease (PD) (Minghetti 2005). Activation of immune cells in the central nervous system leads to the release of proinflammatory factors such as IL-1, IL-2, IL-6 and TNF-a which in turn have cytotoxic effects (neurotoxicity). It ...
Related contentTreatments For Alzheimer's Discussed
10 hours ago ago from For Your Good Health
For Your Good Health Health Related Info December 21 Treatments For Alzheimer's Discussed Alzheimer s disease Like most diseases, those who have Alzheimer's or those who are family members or close friends of those who have Alzheimer's disease may be looking ...
Related contentThe 36-Hour Day: A Family Guide to Caring for People with Alzheimer Disease, Other Dementias, and Memory Loss in Later Life, 4th Edition
23 hours ago ago from Help Alzheimers
ISBN13: 9780801885099 Condition: NEW Notes: Brand New from Publisher. No Remainder Mark. Product Description Revised in 2006 for its twenty-fifth anniversary, this best-selling book is the for families caring for people with Alzheimer disease, offering comfort and support to millions worldwide. In addition to the practical and compassionate guidance that have made The 36-Hour Day invaluable to caregivers, the fourth edition is the only ...
Related contentNo Title
1 day ago ago from Amyloid
Imaging Test Detects Alzheimer's Disease ( Alzheimer's disease can be detected by screening an individual's cerebrospinal fluid for biomarkers ) P l ease Hel p S uppo rt Alz heim er's Research To day! You r Alzhei me r' s do na tion will help billi ons liv e with out it. Donate on line now Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's ...
Related contentLRRK2 variant associated with Alzheimer’s disease.
14 hours ago ago from Research Papers, Journals, Pubmed
LRRK2 variant associated with Alzheimer's disease. Neurobiol Aging. 2009 Dec 15; Authors: Zhao Y, Ho P, Yih Y, Chen C, Lee WL, Tan EK Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations. We analyzed a LRRK2 PD (R1628P) risk variant in a group of 885 subjects comprising of AD and controls. The ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
